ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Naloxegol Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-4T11873
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Naloxegol Market Research Report 2022
BUY CHAPTERS

Global Naloxegol Market Research Report 2024

Code: QYRE-Auto-4T11873
Report
May 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
Aurobindo
MSN Life Sciences
Daiichi Sankyo Company
Knight Therapeutics
Nektar Therapeutics
RedHill Biopharma Ltd
MOVANTIK
Kyowa Kirin International

Naloxegol Market

The global Naloxegol market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Naloxegol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Naloxegol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Naloxegol in Pharmacy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Naloxegol include MOVANTIK, AstraZeneca, Aurobindo, MSN Life Sciences, Lepu, Daiichi Sankyo Company, Knight Therapeutics, Kyowa Kirin International and Nektar Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Naloxegol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Naloxegol.

Report Scope

The Naloxegol market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Naloxegol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Naloxegol companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Naloxegol Market Report

Report Metric Details
Report Name Naloxegol Market
Segment by Type
  • Tablet
  • Capsule
Segment by Application
  • Pharmacy
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company MOVANTIK, AstraZeneca, Aurobindo, MSN Life Sciences, Lepu, Daiichi Sankyo Company, Knight Therapeutics, Kyowa Kirin International, Nektar Therapeutics, RedHill Biopharma Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Naloxegol companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Naloxegol Market report?

Ans: The main players in the Naloxegol Market are MOVANTIK, AstraZeneca, Aurobindo, MSN Life Sciences, Lepu, Daiichi Sankyo Company, Knight Therapeutics, Kyowa Kirin International, Nektar Therapeutics, RedHill Biopharma Ltd.

What are the Application segmentation covered in the Naloxegol Market report?

Ans: The Applications covered in the Naloxegol Market report are Pharmacy, Hospital, Clinic, Others

What are the Type segmentation covered in the Naloxegol Market report?

Ans: The Types covered in the Naloxegol Market report are Tablet, Capsule

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Naloxegol Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tablet
1.2.3 Capsule
1.3 Market by Application
1.3.1 Global Naloxegol Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmacy
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Naloxegol Market Perspective (2019-2030)
2.2 Naloxegol Growth Trends by Region
2.2.1 Global Naloxegol Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Naloxegol Historic Market Size by Region (2019-2024)
2.2.3 Naloxegol Forecasted Market Size by Region (2025-2030)
2.3 Naloxegol Market Dynamics
2.3.1 Naloxegol Industry Trends
2.3.2 Naloxegol Market Drivers
2.3.3 Naloxegol Market Challenges
2.3.4 Naloxegol Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Naloxegol Players by Revenue
3.1.1 Global Top Naloxegol Players by Revenue (2019-2024)
3.1.2 Global Naloxegol Revenue Market Share by Players (2019-2024)
3.2 Global Naloxegol Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Naloxegol Revenue
3.4 Global Naloxegol Market Concentration Ratio
3.4.1 Global Naloxegol Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Naloxegol Revenue in 2023
3.5 Naloxegol Key Players Head office and Area Served
3.6 Key Players Naloxegol Product Solution and Service
3.7 Date of Enter into Naloxegol Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Naloxegol Breakdown Data by Type
4.1 Global Naloxegol Historic Market Size by Type (2019-2024)
4.2 Global Naloxegol Forecasted Market Size by Type (2025-2030)
5 Naloxegol Breakdown Data by Application
5.1 Global Naloxegol Historic Market Size by Application (2019-2024)
5.2 Global Naloxegol Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Naloxegol Market Size (2019-2030)
6.2 North America Naloxegol Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Naloxegol Market Size by Country (2019-2024)
6.4 North America Naloxegol Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Naloxegol Market Size (2019-2030)
7.2 Europe Naloxegol Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Naloxegol Market Size by Country (2019-2024)
7.4 Europe Naloxegol Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Naloxegol Market Size (2019-2030)
8.2 Asia-Pacific Naloxegol Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Naloxegol Market Size by Region (2019-2024)
8.4 Asia-Pacific Naloxegol Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Naloxegol Market Size (2019-2030)
9.2 Latin America Naloxegol Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Naloxegol Market Size by Country (2019-2024)
9.4 Latin America Naloxegol Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Naloxegol Market Size (2019-2030)
10.2 Middle East & Africa Naloxegol Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Naloxegol Market Size by Country (2019-2024)
10.4 Middle East & Africa Naloxegol Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MOVANTIK
11.1.1 MOVANTIK Company Detail
11.1.2 MOVANTIK Business Overview
11.1.3 MOVANTIK Naloxegol Introduction
11.1.4 MOVANTIK Revenue in Naloxegol Business (2019-2024)
11.1.5 MOVANTIK Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Naloxegol Introduction
11.2.4 AstraZeneca Revenue in Naloxegol Business (2019-2024)
11.2.5 AstraZeneca Recent Development
11.3 Aurobindo
11.3.1 Aurobindo Company Detail
11.3.2 Aurobindo Business Overview
11.3.3 Aurobindo Naloxegol Introduction
11.3.4 Aurobindo Revenue in Naloxegol Business (2019-2024)
11.3.5 Aurobindo Recent Development
11.4 MSN Life Sciences
11.4.1 MSN Life Sciences Company Detail
11.4.2 MSN Life Sciences Business Overview
11.4.3 MSN Life Sciences Naloxegol Introduction
11.4.4 MSN Life Sciences Revenue in Naloxegol Business (2019-2024)
11.4.5 MSN Life Sciences Recent Development
11.5 Lepu
11.5.1 Lepu Company Detail
11.5.2 Lepu Business Overview
11.5.3 Lepu Naloxegol Introduction
11.5.4 Lepu Revenue in Naloxegol Business (2019-2024)
11.5.5 Lepu Recent Development
11.6 Daiichi Sankyo Company
11.6.1 Daiichi Sankyo Company Company Detail
11.6.2 Daiichi Sankyo Company Business Overview
11.6.3 Daiichi Sankyo Company Naloxegol Introduction
11.6.4 Daiichi Sankyo Company Revenue in Naloxegol Business (2019-2024)
11.6.5 Daiichi Sankyo Company Recent Development
11.7 Knight Therapeutics
11.7.1 Knight Therapeutics Company Detail
11.7.2 Knight Therapeutics Business Overview
11.7.3 Knight Therapeutics Naloxegol Introduction
11.7.4 Knight Therapeutics Revenue in Naloxegol Business (2019-2024)
11.7.5 Knight Therapeutics Recent Development
11.8 Kyowa Kirin International
11.8.1 Kyowa Kirin International Company Detail
11.8.2 Kyowa Kirin International Business Overview
11.8.3 Kyowa Kirin International Naloxegol Introduction
11.8.4 Kyowa Kirin International Revenue in Naloxegol Business (2019-2024)
11.8.5 Kyowa Kirin International Recent Development
11.9 Nektar Therapeutics
11.9.1 Nektar Therapeutics Company Detail
11.9.2 Nektar Therapeutics Business Overview
11.9.3 Nektar Therapeutics Naloxegol Introduction
11.9.4 Nektar Therapeutics Revenue in Naloxegol Business (2019-2024)
11.9.5 Nektar Therapeutics Recent Development
11.10 RedHill Biopharma Ltd.
11.10.1 RedHill Biopharma Ltd. Company Detail
11.10.2 RedHill Biopharma Ltd. Business Overview
11.10.3 RedHill Biopharma Ltd. Naloxegol Introduction
11.10.4 RedHill Biopharma Ltd. Revenue in Naloxegol Business (2019-2024)
11.10.5 RedHill Biopharma Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Astrazeneca plc
Aurobindo
MSN Life Sciences
Daiichi Sankyo Company
Knight Therapeutics
Nektar Therapeutics
RedHill Biopharma Ltd
MOVANTIK
Kyowa Kirin International
List of Tables
    Table 1. Global Naloxegol Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Tablet
    Table 3. Key Players of Capsule
    Table 4. Global Naloxegol Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Naloxegol Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Naloxegol Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Naloxegol Market Share by Region (2019-2024)
    Table 8. Global Naloxegol Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Naloxegol Market Share by Region (2025-2030)
    Table 10. Naloxegol Market Trends
    Table 11. Naloxegol Market Drivers
    Table 12. Naloxegol Market Challenges
    Table 13. Naloxegol Market Restraints
    Table 14. Global Naloxegol Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Naloxegol Market Share by Players (2019-2024)
    Table 16. Global Top Naloxegol Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Naloxegol as of 2023)
    Table 17. Ranking of Global Top Naloxegol Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Naloxegol Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Naloxegol Product Solution and Service
    Table 21. Date of Enter into Naloxegol Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Naloxegol Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Naloxegol Revenue Market Share by Type (2019-2024)
    Table 25. Global Naloxegol Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Naloxegol Revenue Market Share by Type (2025-2030)
    Table 27. Global Naloxegol Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Naloxegol Revenue Market Share by Application (2019-2024)
    Table 29. Global Naloxegol Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Naloxegol Revenue Market Share by Application (2025-2030)
    Table 31. North America Naloxegol Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Naloxegol Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Naloxegol Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Naloxegol Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Naloxegol Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Naloxegol Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Naloxegol Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Naloxegol Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Naloxegol Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Naloxegol Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Naloxegol Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Naloxegol Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Naloxegol Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Naloxegol Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Naloxegol Market Size by Country (2025-2030) & (US$ Million)
    Table 46. MOVANTIK Company Detail
    Table 47. MOVANTIK Business Overview
    Table 48. MOVANTIK Naloxegol Product
    Table 49. MOVANTIK Revenue in Naloxegol Business (2019-2024) & (US$ Million)
    Table 50. MOVANTIK Recent Development
    Table 51. AstraZeneca Company Detail
    Table 52. AstraZeneca Business Overview
    Table 53. AstraZeneca Naloxegol Product
    Table 54. AstraZeneca Revenue in Naloxegol Business (2019-2024) & (US$ Million)
    Table 55. AstraZeneca Recent Development
    Table 56. Aurobindo Company Detail
    Table 57. Aurobindo Business Overview
    Table 58. Aurobindo Naloxegol Product
    Table 59. Aurobindo Revenue in Naloxegol Business (2019-2024) & (US$ Million)
    Table 60. Aurobindo Recent Development
    Table 61. MSN Life Sciences Company Detail
    Table 62. MSN Life Sciences Business Overview
    Table 63. MSN Life Sciences Naloxegol Product
    Table 64. MSN Life Sciences Revenue in Naloxegol Business (2019-2024) & (US$ Million)
    Table 65. MSN Life Sciences Recent Development
    Table 66. Lepu Company Detail
    Table 67. Lepu Business Overview
    Table 68. Lepu Naloxegol Product
    Table 69. Lepu Revenue in Naloxegol Business (2019-2024) & (US$ Million)
    Table 70. Lepu Recent Development
    Table 71. Daiichi Sankyo Company Company Detail
    Table 72. Daiichi Sankyo Company Business Overview
    Table 73. Daiichi Sankyo Company Naloxegol Product
    Table 74. Daiichi Sankyo Company Revenue in Naloxegol Business (2019-2024) & (US$ Million)
    Table 75. Daiichi Sankyo Company Recent Development
    Table 76. Knight Therapeutics Company Detail
    Table 77. Knight Therapeutics Business Overview
    Table 78. Knight Therapeutics Naloxegol Product
    Table 79. Knight Therapeutics Revenue in Naloxegol Business (2019-2024) & (US$ Million)
    Table 80. Knight Therapeutics Recent Development
    Table 81. Kyowa Kirin International Company Detail
    Table 82. Kyowa Kirin International Business Overview
    Table 83. Kyowa Kirin International Naloxegol Product
    Table 84. Kyowa Kirin International Revenue in Naloxegol Business (2019-2024) & (US$ Million)
    Table 85. Kyowa Kirin International Recent Development
    Table 86. Nektar Therapeutics Company Detail
    Table 87. Nektar Therapeutics Business Overview
    Table 88. Nektar Therapeutics Naloxegol Product
    Table 89. Nektar Therapeutics Revenue in Naloxegol Business (2019-2024) & (US$ Million)
    Table 90. Nektar Therapeutics Recent Development
    Table 91. RedHill Biopharma Ltd. Company Detail
    Table 92. RedHill Biopharma Ltd. Business Overview
    Table 93. RedHill Biopharma Ltd. Naloxegol Product
    Table 94. RedHill Biopharma Ltd. Revenue in Naloxegol Business (2019-2024) & (US$ Million)
    Table 95. RedHill Biopharma Ltd. Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Naloxegol Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Naloxegol Market Share by Type: 2023 VS 2030
    Figure 3. Tablet Features
    Figure 4. Capsule Features
    Figure 5. Global Naloxegol Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Naloxegol Market Share by Application: 2023 VS 2030
    Figure 7. Pharmacy Case Studies
    Figure 8. Hospital Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Others Case Studies
    Figure 11. Naloxegol Report Years Considered
    Figure 12. Global Naloxegol Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Naloxegol Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Naloxegol Market Share by Region: 2023 VS 2030
    Figure 15. Global Naloxegol Market Share by Players in 2023
    Figure 16. Global Top Naloxegol Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Naloxegol as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Naloxegol Revenue in 2023
    Figure 18. North America Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Naloxegol Market Share by Country (2019-2030)
    Figure 20. United States Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Naloxegol Market Share by Country (2019-2030)
    Figure 24. Germany Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. France Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. U.K. Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Italy Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Russia Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Nordic Countries Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Naloxegol Market Share by Region (2019-2030)
    Figure 32. China Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Japan Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. South Korea Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Southeast Asia Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. India Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Australia Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Naloxegol Market Share by Country (2019-2030)
    Figure 40. Mexico Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Brazil Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Naloxegol Market Share by Country (2019-2030)
    Figure 44. Turkey Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Saudi Arabia Naloxegol Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. MOVANTIK Revenue Growth Rate in Naloxegol Business (2019-2024)
    Figure 47. AstraZeneca Revenue Growth Rate in Naloxegol Business (2019-2024)
    Figure 48. Aurobindo Revenue Growth Rate in Naloxegol Business (2019-2024)
    Figure 49. MSN Life Sciences Revenue Growth Rate in Naloxegol Business (2019-2024)
    Figure 50. Lepu Revenue Growth Rate in Naloxegol Business (2019-2024)
    Figure 51. Daiichi Sankyo Company Revenue Growth Rate in Naloxegol Business (2019-2024)
    Figure 52. Knight Therapeutics Revenue Growth Rate in Naloxegol Business (2019-2024)
    Figure 53. Kyowa Kirin International Revenue Growth Rate in Naloxegol Business (2019-2024)
    Figure 54. Nektar Therapeutics Revenue Growth Rate in Naloxegol Business (2019-2024)
    Figure 55. RedHill Biopharma Ltd. Revenue Growth Rate in Naloxegol Business (2019-2024)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Galaxolide Market Research Report 2024
Global Adoxal Market Research Report 2024
Global Octyl Octanoate Market Research Report 2024
Global Naloxone Spray Market Research Report 2024
Global Norfloxacin Market Research Report 2024
Global Cymoxanil Market Research Report 2024
Global Letrozole Market Research Report 2024
N octanol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Naloxone Hydrochloride Injection Market Research Report 2024
Global Carteolol Hydrochloride Market Research Report 2025
Global Altrenogest Market Research Report 2025
Global Oxazole Market Research Report 2025
Global Naldemedine Market Research Report 2024
Global Allyloxypolyethyleneglycol Market Research Report 2024
Global Letrozole Tablets Market Research Report 2024
Global Ambroxol HCl Market Research Report 2024
Global Sodium Ethanethiolate Market Research Report 2025
Global Meloxicam Tablets Market Research Report 2024
Global NaBr Market Research Report 2024
Global Sodium Glucuronic Acid Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions